Pacira BioSciences, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Pacira BioSciences, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Pacira BioSciences, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $3.22M, a 14.5% decline year-over-year.
  • Pacira BioSciences, Inc. annual Operating Lease, Payments for 2024 was $13M, a 8.89% decline from 2023.
  • Pacira BioSciences, Inc. annual Operating Lease, Payments for 2023 was $14.3M, a 0.68% decline from 2022.
  • Pacira BioSciences, Inc. annual Operating Lease, Payments for 2022 was $14.4M, a 13% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.22M -$544K -14.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $3.76M +$484K +14.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $3.28M -$1.32M -28.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $4.6M +$1.84M +66.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q2 2020 $8.5M +$5.38M +172% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $2.76M +$709K +34.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q2 2019 $3.12M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $2.05M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.